nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0899	0.213	CbGbCtD
Bexarotene—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0681	0.162	CbGbCtD
Bexarotene—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0585	0.139	CbGbCtD
Bexarotene—CYP3A4—Betamethasone—ankylosing spondylitis	0.0585	0.139	CbGbCtD
Bexarotene—CYP3A4—Prednisolone—ankylosing spondylitis	0.0577	0.137	CbGbCtD
Bexarotene—CYP3A4—Prednisone—ankylosing spondylitis	0.0545	0.129	CbGbCtD
Bexarotene—CYP3A4—Dexamethasone—ankylosing spondylitis	0.034	0.0808	CbGbCtD
Bexarotene—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000743	0.00128	CcSEcCtD
Bexarotene—Eye disorder—Prednisone—ankylosing spondylitis	0.000742	0.00128	CcSEcCtD
Bexarotene—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00074	0.00128	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000738	0.00127	CcSEcCtD
Bexarotene—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000736	0.00127	CcSEcCtD
Bexarotene—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000736	0.00127	CcSEcCtD
Bexarotene—Discomfort—Triamcinolone—ankylosing spondylitis	0.000735	0.00127	CcSEcCtD
Bexarotene—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000734	0.00127	CcSEcCtD
Bexarotene—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000728	0.00126	CcSEcCtD
Bexarotene—Stomatitis—Methotrexate—ankylosing spondylitis	0.00072	0.00124	CcSEcCtD
Bexarotene—Angiopathy—Prednisone—ankylosing spondylitis	0.00072	0.00124	CcSEcCtD
Bexarotene—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000718	0.00124	CcSEcCtD
Bexarotene—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000718	0.00124	CcSEcCtD
Bexarotene—Malaise—Betamethasone—ankylosing spondylitis	0.000715	0.00124	CcSEcCtD
Bexarotene—Malaise—Dexamethasone—ankylosing spondylitis	0.000715	0.00124	CcSEcCtD
Bexarotene—Oedema—Triamcinolone—ankylosing spondylitis	0.000714	0.00123	CcSEcCtD
Bexarotene—Vertigo—Dexamethasone—ankylosing spondylitis	0.000713	0.00123	CcSEcCtD
Bexarotene—Vertigo—Betamethasone—ankylosing spondylitis	0.000713	0.00123	CcSEcCtD
Bexarotene—Syncope—Betamethasone—ankylosing spondylitis	0.000711	0.00123	CcSEcCtD
Bexarotene—Syncope—Dexamethasone—ankylosing spondylitis	0.000711	0.00123	CcSEcCtD
Bexarotene—Arrhythmia—Prednisone—ankylosing spondylitis	0.000709	0.00122	CcSEcCtD
Bexarotene—Infection—Triamcinolone—ankylosing spondylitis	0.000709	0.00122	CcSEcCtD
Bexarotene—Sweating—Methotrexate—ankylosing spondylitis	0.000708	0.00122	CcSEcCtD
Bexarotene—Infection—Methylprednisolone—ankylosing spondylitis	0.000707	0.00122	CcSEcCtD
Bexarotene—Haematuria—Methotrexate—ankylosing spondylitis	0.000704	0.00122	CcSEcCtD
Bexarotene—Shock—Triamcinolone—ankylosing spondylitis	0.000702	0.00121	CcSEcCtD
Bexarotene—Insomnia—Prednisolone—ankylosing spondylitis	0.000702	0.00121	CcSEcCtD
Bexarotene—Alopecia—Prednisone—ankylosing spondylitis	0.000701	0.00121	CcSEcCtD
Bexarotene—Shock—Methylprednisolone—ankylosing spondylitis	0.0007	0.00121	CcSEcCtD
Bexarotene—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000698	0.00121	CcSEcCtD
Bexarotene—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000697	0.0012	CcSEcCtD
Bexarotene—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000697	0.0012	CcSEcCtD
Bexarotene—Epistaxis—Methotrexate—ankylosing spondylitis	0.000697	0.0012	CcSEcCtD
Bexarotene—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000697	0.0012	CcSEcCtD
Bexarotene—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000696	0.0012	CcSEcCtD
Bexarotene—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000695	0.0012	CcSEcCtD
Bexarotene—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000692	0.00119	CcSEcCtD
Bexarotene—Malnutrition—Prednisone—ankylosing spondylitis	0.000691	0.00119	CcSEcCtD
Bexarotene—Erythema—Prednisone—ankylosing spondylitis	0.000691	0.00119	CcSEcCtD
Bexarotene—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00069	0.00119	CcSEcCtD
Bexarotene—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000688	0.00119	CcSEcCtD
Bexarotene—Hypertension—Dexamethasone—ankylosing spondylitis	0.000685	0.00118	CcSEcCtD
Bexarotene—Hypertension—Betamethasone—ankylosing spondylitis	0.000685	0.00118	CcSEcCtD
Bexarotene—Myalgia—Dexamethasone—ankylosing spondylitis	0.000675	0.00117	CcSEcCtD
Bexarotene—Myalgia—Betamethasone—ankylosing spondylitis	0.000675	0.00117	CcSEcCtD
Bexarotene—Anxiety—Betamethasone—ankylosing spondylitis	0.000673	0.00116	CcSEcCtD
Bexarotene—Anxiety—Dexamethasone—ankylosing spondylitis	0.000673	0.00116	CcSEcCtD
Bexarotene—Discomfort—Betamethasone—ankylosing spondylitis	0.000667	0.00115	CcSEcCtD
Bexarotene—Discomfort—Dexamethasone—ankylosing spondylitis	0.000667	0.00115	CcSEcCtD
Bexarotene—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000667	0.00115	CcSEcCtD
Bexarotene—Pain—Prednisolone—ankylosing spondylitis	0.000664	0.00115	CcSEcCtD
Bexarotene—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000663	0.00115	CcSEcCtD
Bexarotene—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000658	0.00114	CcSEcCtD
Bexarotene—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000655	0.00113	CcSEcCtD
Bexarotene—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00065	0.00112	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00065	0.00112	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000649	0.00112	CcSEcCtD
Bexarotene—Oedema—Betamethasone—ankylosing spondylitis	0.000647	0.00112	CcSEcCtD
Bexarotene—Oedema—Dexamethasone—ankylosing spondylitis	0.000647	0.00112	CcSEcCtD
Bexarotene—Insomnia—Triamcinolone—ankylosing spondylitis	0.000645	0.00111	CcSEcCtD
Bexarotene—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000644	0.00111	CcSEcCtD
Bexarotene—Infection—Betamethasone—ankylosing spondylitis	0.000643	0.00111	CcSEcCtD
Bexarotene—Infection—Dexamethasone—ankylosing spondylitis	0.000643	0.00111	CcSEcCtD
Bexarotene—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000641	0.00111	CcSEcCtD
Bexarotene—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000641	0.00111	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000639	0.0011	CcSEcCtD
Bexarotene—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000639	0.0011	CcSEcCtD
Bexarotene—Anaemia—Prednisone—ankylosing spondylitis	0.000639	0.0011	CcSEcCtD
Bexarotene—Shock—Dexamethasone—ankylosing spondylitis	0.000637	0.0011	CcSEcCtD
Bexarotene—Shock—Betamethasone—ankylosing spondylitis	0.000637	0.0011	CcSEcCtD
Bexarotene—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000636	0.0011	CcSEcCtD
Bexarotene—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000635	0.0011	CcSEcCtD
Bexarotene—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000635	0.0011	CcSEcCtD
Bexarotene—Agitation—Prednisone—ankylosing spondylitis	0.000635	0.0011	CcSEcCtD
Bexarotene—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000634	0.0011	CcSEcCtD
Bexarotene—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000634	0.0011	CcSEcCtD
Bexarotene—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000632	0.00109	CcSEcCtD
Bexarotene—Tachycardia—Betamethasone—ankylosing spondylitis	0.000632	0.00109	CcSEcCtD
Bexarotene—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000628	0.00108	CcSEcCtD
Bexarotene—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000627	0.00108	CcSEcCtD
Bexarotene—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000626	0.00108	CcSEcCtD
Bexarotene—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000626	0.00108	CcSEcCtD
Bexarotene—Malaise—Prednisone—ankylosing spondylitis	0.000623	0.00108	CcSEcCtD
Bexarotene—Vertigo—Prednisone—ankylosing spondylitis	0.000621	0.00107	CcSEcCtD
Bexarotene—Eye disorder—Methotrexate—ankylosing spondylitis	0.00062	0.00107	CcSEcCtD
Bexarotene—Syncope—Prednisone—ankylosing spondylitis	0.00062	0.00107	CcSEcCtD
Bexarotene—Tinnitus—Methotrexate—ankylosing spondylitis	0.000618	0.00107	CcSEcCtD
Bexarotene—Anorexia—Dexamethasone—ankylosing spondylitis	0.000617	0.00107	CcSEcCtD
Bexarotene—Anorexia—Betamethasone—ankylosing spondylitis	0.000617	0.00107	CcSEcCtD
Bexarotene—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000616	0.00106	CcSEcCtD
Bexarotene—Fatigue—Triamcinolone—ankylosing spondylitis	0.000615	0.00106	CcSEcCtD
Bexarotene—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000614	0.00106	CcSEcCtD
Bexarotene—Pain—Triamcinolone—ankylosing spondylitis	0.00061	0.00105	CcSEcCtD
Bexarotene—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000607	0.00105	CcSEcCtD
Bexarotene—Angiopathy—Methotrexate—ankylosing spondylitis	0.000602	0.00104	CcSEcCtD
Bexarotene—Hypertension—Prednisone—ankylosing spondylitis	0.000597	0.00103	CcSEcCtD
Bexarotene—Chills—Methotrexate—ankylosing spondylitis	0.000595	0.00103	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00059	0.00102	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00059	0.00102	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—ankylosing spondylitis	0.000588	0.00102	CcSEcCtD
Bexarotene—Myalgia—Prednisone—ankylosing spondylitis	0.000588	0.00102	CcSEcCtD
Bexarotene—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000588	0.00102	CcSEcCtD
Bexarotene—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000587	0.00101	CcSEcCtD
Bexarotene—Anxiety—Prednisone—ankylosing spondylitis	0.000586	0.00101	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—ankylosing spondylitis	0.000586	0.00101	CcSEcCtD
Bexarotene—Insomnia—Dexamethasone—ankylosing spondylitis	0.000586	0.00101	CcSEcCtD
Bexarotene—Insomnia—Betamethasone—ankylosing spondylitis	0.000586	0.00101	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000584	0.00101	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000582	0.00101	CcSEcCtD
Bexarotene—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000581	0.001	CcSEcCtD
Bexarotene—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000581	0.001	CcSEcCtD
Bexarotene—Discomfort—Prednisone—ankylosing spondylitis	0.000581	0.001	CcSEcCtD
Bexarotene—Erythema—Methotrexate—ankylosing spondylitis	0.000577	0.000997	CcSEcCtD
Bexarotene—Malnutrition—Methotrexate—ankylosing spondylitis	0.000577	0.000997	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000572	0.000987	CcSEcCtD
Bexarotene—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00057	0.000984	CcSEcCtD
Bexarotene—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00057	0.000984	CcSEcCtD
Bexarotene—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000565	0.000977	CcSEcCtD
Bexarotene—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000564	0.000974	CcSEcCtD
Bexarotene—Oedema—Prednisone—ankylosing spondylitis	0.000564	0.000974	CcSEcCtD
Bexarotene—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000563	0.000972	CcSEcCtD
Bexarotene—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000563	0.000972	CcSEcCtD
Bexarotene—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000563	0.000972	CcSEcCtD
Bexarotene—Infection—Prednisone—ankylosing spondylitis	0.00056	0.000968	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000559	0.000966	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000559	0.000966	CcSEcCtD
Bexarotene—Back pain—Methotrexate—ankylosing spondylitis	0.000559	0.000965	CcSEcCtD
Bexarotene—Fatigue—Betamethasone—ankylosing spondylitis	0.000558	0.000964	CcSEcCtD
Bexarotene—Fatigue—Dexamethasone—ankylosing spondylitis	0.000558	0.000964	CcSEcCtD
Bexarotene—Shock—Prednisone—ankylosing spondylitis	0.000555	0.000958	CcSEcCtD
Bexarotene—Pain—Dexamethasone—ankylosing spondylitis	0.000554	0.000956	CcSEcCtD
Bexarotene—Pain—Betamethasone—ankylosing spondylitis	0.000554	0.000956	CcSEcCtD
Bexarotene—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000553	0.000955	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—ankylosing spondylitis	0.00055	0.000951	CcSEcCtD
Bexarotene—Skin disorder—Prednisone—ankylosing spondylitis	0.000548	0.000946	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000545	0.000942	CcSEcCtD
Bexarotene—Anorexia—Prednisone—ankylosing spondylitis	0.000537	0.000928	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000536	0.000925	CcSEcCtD
Bexarotene—Anaemia—Methotrexate—ankylosing spondylitis	0.000534	0.000922	CcSEcCtD
Bexarotene—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000534	0.000922	CcSEcCtD
Bexarotene—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000534	0.000922	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000529	0.000915	CcSEcCtD
Bexarotene—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000529	0.000915	CcSEcCtD
Bexarotene—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000526	0.000908	CcSEcCtD
Bexarotene—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000525	0.000906	CcSEcCtD
Bexarotene—Malaise—Methotrexate—ankylosing spondylitis	0.000521	0.000899	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—ankylosing spondylitis	0.000519	0.000896	CcSEcCtD
Bexarotene—Leukopenia—Methotrexate—ankylosing spondylitis	0.000517	0.000893	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000514	0.000887	CcSEcCtD
Bexarotene—Dizziness—Prednisolone—ankylosing spondylitis	0.000513	0.000886	CcSEcCtD
Bexarotene—Asthenia—Triamcinolone—ankylosing spondylitis	0.000512	0.000884	CcSEcCtD
Bexarotene—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000512	0.000884	CcSEcCtD
Bexarotene—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000512	0.000884	CcSEcCtD
Bexarotene—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000512	0.000884	CcSEcCtD
Bexarotene—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000512	0.000884	CcSEcCtD
Bexarotene—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000511	0.000882	CcSEcCtD
Bexarotene—Insomnia—Prednisone—ankylosing spondylitis	0.00051	0.000881	CcSEcCtD
Bexarotene—Paraesthesia—Prednisone—ankylosing spondylitis	0.000506	0.000875	CcSEcCtD
Bexarotene—Pruritus—Triamcinolone—ankylosing spondylitis	0.000505	0.000872	CcSEcCtD
Bexarotene—Cough—Methotrexate—ankylosing spondylitis	0.000504	0.00087	CcSEcCtD
Bexarotene—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000504	0.00087	CcSEcCtD
Bexarotene—Dyspepsia—Prednisone—ankylosing spondylitis	0.000496	0.000857	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—ankylosing spondylitis	0.000492	0.000849	CcSEcCtD
Bexarotene—Chest pain—Methotrexate—ankylosing spondylitis	0.000492	0.000849	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—ankylosing spondylitis	0.000492	0.000849	CcSEcCtD
Bexarotene—Decreased appetite—Prednisone—ankylosing spondylitis	0.00049	0.000847	CcSEcCtD
Bexarotene—Rash—Prednisolone—ankylosing spondylitis	0.000489	0.000845	CcSEcCtD
Bexarotene—Dermatitis—Prednisolone—ankylosing spondylitis	0.000489	0.000844	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000488	0.000843	CcSEcCtD
Bexarotene—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000487	0.000841	CcSEcCtD
Bexarotene—Fatigue—Prednisone—ankylosing spondylitis	0.000486	0.00084	CcSEcCtD
Bexarotene—Headache—Prednisolone—ankylosing spondylitis	0.000486	0.00084	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—ankylosing spondylitis	0.000486	0.000839	CcSEcCtD
Bexarotene—Constipation—Prednisone—ankylosing spondylitis	0.000482	0.000833	CcSEcCtD
Bexarotene—Confusional state—Methotrexate—ankylosing spondylitis	0.000475	0.000821	CcSEcCtD
Bexarotene—Dizziness—Triamcinolone—ankylosing spondylitis	0.000472	0.000815	CcSEcCtD
Bexarotene—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000471	0.000813	CcSEcCtD
Bexarotene—Infection—Methotrexate—ankylosing spondylitis	0.000468	0.000809	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000465	0.000803	CcSEcCtD
Bexarotene—Asthenia—Dexamethasone—ankylosing spondylitis	0.000465	0.000802	CcSEcCtD
Bexarotene—Asthenia—Betamethasone—ankylosing spondylitis	0.000465	0.000802	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000462	0.000798	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000461	0.000797	CcSEcCtD
Bexarotene—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000461	0.000796	CcSEcCtD
Bexarotene—Nausea—Prednisolone—ankylosing spondylitis	0.000461	0.000796	CcSEcCtD
Bexarotene—Pruritus—Betamethasone—ankylosing spondylitis	0.000458	0.000791	CcSEcCtD
Bexarotene—Pruritus—Dexamethasone—ankylosing spondylitis	0.000458	0.000791	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—ankylosing spondylitis	0.000458	0.000791	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000456	0.000787	CcSEcCtD
Bexarotene—Vomiting—Triamcinolone—ankylosing spondylitis	0.000454	0.000784	CcSEcCtD
Bexarotene—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000453	0.000782	CcSEcCtD
Bexarotene—Rash—Triamcinolone—ankylosing spondylitis	0.00045	0.000777	CcSEcCtD
Bexarotene—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00045	0.000776	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—ankylosing spondylitis	0.000449	0.000776	CcSEcCtD
Bexarotene—Rash—Methylprednisolone—ankylosing spondylitis	0.000449	0.000775	CcSEcCtD
Bexarotene—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000449	0.000775	CcSEcCtD
Bexarotene—Headache—Triamcinolone—ankylosing spondylitis	0.000447	0.000772	CcSEcCtD
Bexarotene—Headache—Methylprednisolone—ankylosing spondylitis	0.000446	0.00077	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—ankylosing spondylitis	0.000446	0.00077	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—ankylosing spondylitis	0.000446	0.00077	CcSEcCtD
Bexarotene—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000443	0.000765	CcSEcCtD
Bexarotene—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000443	0.000765	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000429	0.000742	CcSEcCtD
Bexarotene—Dizziness—Dexamethasone—ankylosing spondylitis	0.000428	0.00074	CcSEcCtD
Bexarotene—Dizziness—Betamethasone—ankylosing spondylitis	0.000428	0.00074	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—ankylosing spondylitis	0.000426	0.000736	CcSEcCtD
Bexarotene—Nausea—Triamcinolone—ankylosing spondylitis	0.000424	0.000732	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000423	0.000731	CcSEcCtD
Bexarotene—Nausea—Methylprednisolone—ankylosing spondylitis	0.000423	0.000731	CcSEcCtD
Bexarotene—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00042	0.000726	CcSEcCtD
Bexarotene—Somnolence—Methotrexate—ankylosing spondylitis	0.000419	0.000724	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000415	0.000718	CcSEcCtD
Bexarotene—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000415	0.000717	CcSEcCtD
Bexarotene—Vomiting—Betamethasone—ankylosing spondylitis	0.000412	0.000711	CcSEcCtD
Bexarotene—Vomiting—Dexamethasone—ankylosing spondylitis	0.000412	0.000711	CcSEcCtD
Bexarotene—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00041	0.000708	CcSEcCtD
Bexarotene—Rash—Dexamethasone—ankylosing spondylitis	0.000408	0.000705	CcSEcCtD
Bexarotene—Rash—Betamethasone—ankylosing spondylitis	0.000408	0.000705	CcSEcCtD
Bexarotene—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000408	0.000705	CcSEcCtD
Bexarotene—Dermatitis—Betamethasone—ankylosing spondylitis	0.000408	0.000705	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000407	0.000703	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—ankylosing spondylitis	0.000406	0.000702	CcSEcCtD
Bexarotene—Headache—Betamethasone—ankylosing spondylitis	0.000406	0.000701	CcSEcCtD
Bexarotene—Headache—Dexamethasone—ankylosing spondylitis	0.000406	0.000701	CcSEcCtD
Bexarotene—Asthenia—Prednisone—ankylosing spondylitis	0.000405	0.000699	CcSEcCtD
Bexarotene—Pain—Methotrexate—ankylosing spondylitis	0.000403	0.000696	CcSEcCtD
Bexarotene—Pruritus—Prednisone—ankylosing spondylitis	0.000399	0.000689	CcSEcCtD
Bexarotene—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000388	0.000671	CcSEcCtD
Bexarotene—Diarrhoea—Prednisone—ankylosing spondylitis	0.000386	0.000666	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000385	0.000666	CcSEcCtD
Bexarotene—Nausea—Betamethasone—ankylosing spondylitis	0.000385	0.000664	CcSEcCtD
Bexarotene—Nausea—Dexamethasone—ankylosing spondylitis	0.000385	0.000664	CcSEcCtD
Bexarotene—Dizziness—Prednisone—ankylosing spondylitis	0.000373	0.000644	CcSEcCtD
Bexarotene—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000373	0.000643	CcSEcCtD
Bexarotene—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000373	0.000643	CcSEcCtD
Bexarotene—Vomiting—Prednisone—ankylosing spondylitis	0.000359	0.000619	CcSEcCtD
Bexarotene—Rash—Prednisone—ankylosing spondylitis	0.000356	0.000614	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—ankylosing spondylitis	0.000355	0.000614	CcSEcCtD
Bexarotene—Headache—Prednisone—ankylosing spondylitis	0.000353	0.00061	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000347	0.0006	CcSEcCtD
Bexarotene—Asthenia—Methotrexate—ankylosing spondylitis	0.000338	0.000584	CcSEcCtD
Bexarotene—Nausea—Prednisone—ankylosing spondylitis	0.000335	0.000579	CcSEcCtD
Bexarotene—Pruritus—Methotrexate—ankylosing spondylitis	0.000333	0.000576	CcSEcCtD
Bexarotene—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000322	0.000557	CcSEcCtD
Bexarotene—Dizziness—Methotrexate—ankylosing spondylitis	0.000312	0.000538	CcSEcCtD
Bexarotene—Vomiting—Methotrexate—ankylosing spondylitis	0.0003	0.000518	CcSEcCtD
Bexarotene—Rash—Methotrexate—ankylosing spondylitis	0.000297	0.000513	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—ankylosing spondylitis	0.000297	0.000513	CcSEcCtD
Bexarotene—Headache—Methotrexate—ankylosing spondylitis	0.000295	0.00051	CcSEcCtD
Bexarotene—Nausea—Methotrexate—ankylosing spondylitis	0.00028	0.000483	CcSEcCtD
